We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

139 hedge funds and large institutions have $1.58B invested in IVERIC bio, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 24 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 24

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

13% more capital invested

Capital invested by funds: $1.4B → $1.58B (+$179M)

8% more funds holding

Funds holding: 129139 (+10)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

18% less call options, than puts

Call options by funds: $7.62M | Put options by funds: $9.33M

Holders
139
Holders Change
+10
Holders Change %
+7.75%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
30
Increased
71
Reduced
24
Closed
20
Calls
$7.62M
Puts
$9.33M
Net Calls
-$1.72M
Net Calls Change
-$274K
Name Holding Trade Value Shares
Change
Change in
Stake
CIP
51
Convergence Investment Partners
Florida
$2.21M +$2.11M +42,370 New
PI
52
Putnam Investments
Massachusetts
$2.18M +$2.09M +41,929 New
SOMRS
53
State of Michigan Retirement System
Michigan
$2.18M +$2.08M +41,809 New
TD Asset Management
54
TD Asset Management
Ontario, Canada
$2.1M +$642K +12,900 +47%
Wells Fargo
55
Wells Fargo
California
$1.96M +$126K +2,524 +7%
BBA
56
Baker Bros. Advisors
New York
$1.86M
OC
57
Oppenheimer & Co
New York
$1.86M +$14.3K +287 +0.8%
TA
58
Teachers Advisors
New York
$1.79M +$526K +10,578 +44%
AA
59
ALPS Advisors
Colorado
$1.77M +$863K +17,350 +104%
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$1.72M +$1.62M +32,638 +9,772%
Millennium Management
61
Millennium Management
New York
$1.64M -$2.55M -51,169 -62%
ProShare Advisors
62
ProShare Advisors
Maryland
$1.58M +$30K +603 +2%
AI
63
Analytic Investors
California
$1.52M +$573K +11,518 +65%
AQR Capital Management
64
AQR Capital Management
Connecticut
$1.48M +$94K +1,889 +7%
NFA
65
Nationwide Fund Advisors
Ohio
$1.42M +$855K +17,177 +169%
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$1.41M +$483K +9,718 +56%
Swiss National Bank
67
Swiss National Bank
Switzerland
$1.37M +$502K +10,088 +62%
ARTA
68
A.R.T. Advisors
New York
$1.27M +$773K +15,546 +177%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$1.24M +$658K +13,233 +126%
NCCM
70
Nine Chapters Capital Management
New Jersey
$1.23M +$741K +14,900 +169%
Bank of America
71
Bank of America
North Carolina
$1.17M +$802K +16,114 +252%
TAM
72
Tocqueville Asset Management
New York
$1.15M +$1.1M +22,025 New
GC
73
Globeflex Capital
California
$1.12M +$551K +11,068 +105%
Citadel Advisors
74
Citadel Advisors
Florida
$1.11M +$84.1K +1,690 +9%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$1.09M +$1.04M +20,926 New

ISEE Hedge Fund Activity: Q2 2015 in Review

139 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2015, worth a combined $1.58B — up 13% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ISEE positions and 20 closed out — a net gain of 10 holders — while 71 added to existing stakes and 24 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $30.4M. The largest seller was Clarus Ventures, exiting entirely with an estimated $72.3M sold.

  • 139 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2015, up from 129 in Q1 2015.
  • Funds reported $1.58B of IVERIC bio, Inc. Common Stock stock for Q2 2015, up 13% quarter-over-quarter.
  • 30 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2015 and 20 closed out, a net change of +10 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2015 was T. Rowe Price Associates, an estimated $30.4M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2015 was Clarus Ventures, an estimated $72.3M sold.

Based on aggregated 13F filings for Q2 2015.